173 related articles for article (PubMed ID: 15113564)
21. Recombinant Lactococcus lactis for efficient conversion of cellodextrins into L-lactic acid.
Gandini C; Tarraran L; Kalemasi D; Pessione E; Mazzoli R
Biotechnol Bioeng; 2017 Dec; 114(12):2807-2817. PubMed ID: 28802003
[TBL] [Abstract][Full Text] [Related]
22. Enhanced heterologous protein productivity by genome reduction in Lactococcus lactis NZ9000.
Zhu D; Fu Y; Liu F; Xu H; Saris PE; Qiao M
Microb Cell Fact; 2017 Jan; 16(1):1. PubMed ID: 28049473
[TBL] [Abstract][Full Text] [Related]
23. Complete genome sequence of Lactococcus lactis subsp. lactis KLDS4. 0325, a bacterium newly isolated from Koumiss in Xinjiang, China.
Yang X; Wang Y; Zhou Y; Gao X; Li B; Huo G
Wei Sheng Wu Xue Bao; 2014 Dec; 54(12):1406-18. PubMed ID: 25876326
[TBL] [Abstract][Full Text] [Related]
24. Riboflavin bio-enrichment of soy beverage by selected roseoflavin-resistant and engineered lactic acid bacteria.
Langa S; Peirotén Á; Rodríguez S; Calzada J; Prieto-Paredes R; Curiel JA; Landete JM
Int J Food Microbiol; 2024 Feb; 411():110547. PubMed ID: 38150774
[TBL] [Abstract][Full Text] [Related]
25. Functional expression of mouse insulin-like growth factor-I with food-grade vector in Lactococcus lactis NZ9000.
Gao G; Qiao JJ; Yang CH; Jiang DZ; Li RQ; Su JJ; Xu HJ; Zhang XM; Bai YL; Qiao MQ
Lett Appl Microbiol; 2012 May; 54(5):404-9. PubMed ID: 22332956
[TBL] [Abstract][Full Text] [Related]
26. Metabolic engineering of Lactococcus lactis: the impact of genomics and metabolic modelling.
Kleerebezem M; Boels IC; Groot MN; Mierau I; Sybesma W; Hugenholtz J
J Biotechnol; 2002 Sep; 98(2-3):199-213. PubMed ID: 12141987
[TBL] [Abstract][Full Text] [Related]
27. Production of riboflavin by metabolically engineered Corynebacterium ammoniagenes.
Koizumi S; Yonetani Y; Maruyama A; Teshiba S
Appl Microbiol Biotechnol; 2000 Jun; 53(6):674-9. PubMed ID: 10919325
[TBL] [Abstract][Full Text] [Related]
28. Engineering of EPA/DHA omega-3 fatty acid production by Lactococcus lactis subsp. cremoris MG1363.
Amiri-Jami M; Lapointe G; Griffiths MW
Appl Microbiol Biotechnol; 2014 Apr; 98(7):3071-80. PubMed ID: 24389665
[TBL] [Abstract][Full Text] [Related]
29. Resistance to bacteriocin Lcn972 improves oxygen tolerance of Lactococcus lactis IPLA947 without compromising its performance as a dairy starter.
López-González MJ; Campelo AB; Picon A; Rodríguez A; Martínez B
BMC Microbiol; 2018 Jul; 18(1):76. PubMed ID: 30029618
[TBL] [Abstract][Full Text] [Related]
30. Genetic engineering of Ketogulonigenium vulgare for enhanced production of 2-keto-L-gulonic acid.
Cai L; Yuan MQ; Li ZJ; Chen JC; Chen GQ
J Biotechnol; 2012 Jan; 157(2):320-5. PubMed ID: 22192513
[TBL] [Abstract][Full Text] [Related]
31. Transcription analysis of hyaluronan biosynthesis genes in Streptococcus zooepidemicus and metabolically engineered Lactococcus lactis.
Prasad SB; Ramachandran KB; Jayaraman G
Appl Microbiol Biotechnol; 2012 Jun; 94(6):1593-607. PubMed ID: 22367612
[TBL] [Abstract][Full Text] [Related]
32. B-group vitamin production by lactic acid bacteria--current knowledge and potential applications.
LeBlanc JG; Laiño JE; del Valle MJ; Vannini V; van Sinderen D; Taranto MP; de Valdez GF; de Giori GS; Sesma F
J Appl Microbiol; 2011 Dec; 111(6):1297-309. PubMed ID: 21933312
[TBL] [Abstract][Full Text] [Related]
33. Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis.
Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Gruss A; Rodriguez-Padilla C; Saucedo-Cardenas O; Langella P; Montes de Oca-Luna R
Biotechnol Prog; 2003; 19(3):1101-4. PubMed ID: 12790689
[TBL] [Abstract][Full Text] [Related]
34. Production of biologically active human lymphotactin (XCL1) by Lactococcus lactis.
Zavala-Flores LM; Villatoro-Hernandez J; Gamez-Escobedo A; Franco-Molina M; Rangel-Colmenero BR; Villanueva-Olivo A; Gutierrez-Puente Y; de Oca-Luna RM; Valdés-Flores J; Saucedo-Cardenas O
Biotechnol Lett; 2009 Feb; 31(2):215-20. PubMed ID: 18923910
[TBL] [Abstract][Full Text] [Related]
35. Efficient production and optimization of E7 oncoprotein from Iranian human papillomavirus type 16 in Lactococcus lactis using nisin-controlled gene expression (NICE) system.
Mohseni AH; Razavilar V; Keyvani H; Razavi MR; Khavari-Nejad RA
Microb Pathog; 2017 Sep; 110():554-560. PubMed ID: 28754267
[TBL] [Abstract][Full Text] [Related]
36. [Components of fermentation medium regulate bacteriocin synthesis by the recombinant strain Lactococcus lactis subsp. lactis F-116].
Stoianova LG; Levina NA
Mikrobiologiia; 2006; 75(3):342-8. PubMed ID: 16871800
[TBL] [Abstract][Full Text] [Related]
37. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.
Steidler L; Neirynck S; Huyghebaert N; Snoeck V; Vermeire A; Goddeeris B; Cox E; Remon JP; Remaut E
Nat Biotechnol; 2003 Jul; 21(7):785-9. PubMed ID: 12808464
[TBL] [Abstract][Full Text] [Related]
38. Encapsulated Lactococcus lactis with enhanced gastrointestinal survival for the development of folate enriched functional foods.
Divya JB; Nampoothiri KM
Bioresour Technol; 2015; 188():226-30. PubMed ID: 25686721
[TBL] [Abstract][Full Text] [Related]
39. Overproduction of heterologous mannitol 1-phosphatase: a key factor for engineering mannitol production by Lactococcus lactis.
Wisselink HW; Moers AP; Mars AE; Hoefnagel MH; de Vos WM; Hugenholtz J
Appl Environ Microbiol; 2005 Mar; 71(3):1507-14. PubMed ID: 15746354
[TBL] [Abstract][Full Text] [Related]
40. Cloning and production of a novel bacteriocin, lactococcin K, from Lactococcus lactis subsp. lactis MY23.
Kim YS; Kim MJ; Kim P; Kim JH
Biotechnol Lett; 2006 Mar; 28(5):357-62. PubMed ID: 16614924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
